PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 186 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $379,000 | +3.3% | 12,706 | +1.6% | 0.02% | -5.3% |
| Q1 2016 | $367,000 | -69.8% | 12,504 | -19.4% | 0.02% | -67.2% |
| Q4 2015 | $1,216,000 | +3.8% | 15,505 | -0.3% | 0.06% | -13.4% |
| Q3 2015 | $1,172,000 | -37.0% | 15,548 | -2.4% | 0.07% | -13.0% |
| Q2 2015 | $1,860,000 | -53.5% | 15,934 | -6.0% | 0.08% | -50.6% |
| Q1 2015 | $4,001,000 | +48.3% | 16,944 | +18.9% | 0.16% | +41.8% |
| Q4 2014 | $2,698,000 | -11.9% | 14,254 | +11.1% | 0.11% | -23.1% |
| Q3 2014 | $3,062,000 | – | 12,834 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |